Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
RIGEL PHARMACEUTICALS INC has filed 1,458 SEC EDGAR filings since 04 Feb 2000

SEC filing history

Showing 701-725 of 893 matching filings.

Per page
25
Current page
29
SC 13G/A File 005-59985

SCHEDULE 13G

Filing date
07 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59985

SC 13G/A filing

Filing date
30 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
10 Jan 2014
Reporting date
10 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-59985

SC 13G filing

Filing date
27 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
06 Dec 2013
Reporting date
04 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Nov 2013
Reporting date
19 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59985

DISCLOSURE DOCUMENT

Filing date
08 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
05 Nov 2013
Reporting date
05 Nov 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
26 Aug 2013
Reporting date
26 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
06 Aug 2013
Reporting date
06 Aug 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-189523

S-8

Filing date
21 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Jun 2013
Reporting date
07 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
04 Jun 2013
Reporting date
04 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 May 2013
Reporting date
15 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
17 May 2013
Reporting date
14 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
15 May 2013
Reporting date
01 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59985

AMENDMENT NO. 3

Filing date
15 May 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-29889

8-K

Filing date
07 May 2013
Reporting date
07 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .